Finance

Lists
WEB:EBR
Warehouses Estates Belgium SA
₮36,80
-0,81%
(-0,30) 1D
16 āš•.āšĨ., 17 āŧ‚āšĄāš‡ 22 āš™āšēāš—āšĩ 22 āš§āšīāš™āšēāš—āšĩ GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for WEB...
Open
₮37,30
High
₮37,50
Low
₮36,80
Mkt. cap
131,02 āšĨāŧ‰āšēāš™
Avg. vol.
1,14Â āšžāšąāš™
Volume
518,00
Dividend
6,37%
Quarterly dividend
₮0,59
Ex-dividend date
5 āšž.āšž. 2026
P/E ratio
7,35
52-wk high
₮43,80
52-wk low
₮35,20
EPS
₮5,01
Shares outstanding
3,50 āšĨāŧ‰āšēāš™
No. of employees
1
Open
₮37,30
High
₮37,50
Low
₮36,80
Mkt. cap
131,02 āšĨāŧ‰āšēāš™
Avg. vol.
1,14Â āšžāšąāš™
Volume
518,00
Dividend
6,37%
Quarterly dividend
₮0,59
Ex-dividend date
5 āšž.āšž. 2026
P/E ratio
7,35
52-wk high
₮43,80
52-wk low
₮35,20
EPS
₮5,01
Shares outstanding
3,50 āšĨāŧ‰āšēāš™
No. of employees
1
News stories
From web sources and news partners
Investor's Business Daily
Investor's Business Daily
·
1 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
Stock Market Ends Week With Software Sell-Off; Nasdaq Dives 2%, Gives Up 200-Day Line
MarketBeat
MarketBeat
·
14 āš™āšēāš—āšĩāšāŧˆāš­āš™
CRISPR Therapeutics (NASDAQ:CRSP) Director Sells 14,514 Shares of Stock
Investing News Network
Investing News Network
·
29 āš™āšēāš—āšĩāšāŧˆāš­āš™
Kopin to Host Live YouTube "Ask Me Anything" Panel from Nasdaq MarketSite on the Future of AI Infrastructure
Yahoo Finance
Yahoo Finance
·
1 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
About Warehouses Estates Belgium SA
CEO-
Employees1
Founded1985
Headquarters-
SectorReal estate investment trust
Websitew-e-b.be
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
āš.āš. 2025
āš—.āš§. 2025
āšĄ.āš™. 2026
āšĄāšī.āš–. 2026
Revenue
6,70 āšĨāŧ‰āšēāš™
6,70 āšĨāŧ‰āšēāš™
7,83 āšĨāŧ‰āšēāš™
7,83 āšĨāŧ‰āšēāš™
Cost of goods sold
1,09 āšĨāŧ‰āšēāš™
1,09 āšĨāŧ‰āšēāš™
2,64 āšĨāŧ‰āšēāš™
2,64 āšĨāŧ‰āšēāš™
Cost of revenue
1,09 āšĨāŧ‰āšēāš™
1,09 āšĨāŧ‰āšēāš™
2,64 āšĨāŧ‰āšēāš™
2,64 āšĨāŧ‰āšēāš™
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
434,46Â āšžāšąāš™
434,46Â āšžāšąāš™
449,43Â āšžāšąāš™
449,43Â āšžāšąāš™
Operating expense
-1,42 āšĨāŧ‰āšēāš™
-1,42 āšĨāŧ‰āšēāš™
343,18Â āšžāšąāš™
343,18Â āšžāšąāš™
Total operating expenses
-334,50Â āšžāšąāš™
-334,50Â āšžāšąāš™
2,98 āšĨāŧ‰āšēāš™
2,98 āšĨāŧ‰āšēāš™
Operating income
7,04 āšĨāŧ‰āšēāš™
7,04 āšĨāŧ‰āšēāš™
4,85 āšĨāŧ‰āšēāš™
4,85 āšĨāŧ‰āšēāš™
Other non operating income
183,59Â āšžāšąāš™
183,59Â āšžāšąāš™
-14,98Â āšžāšąāš™
-14,98Â āšžāšąāš™
EBT including unusual items
4,56 āšĨāŧ‰āšēāš™
4,56 āšĨāŧ‰āšēāš™
4,23 āšĨāŧ‰āšēāš™
4,23 āšĨāŧ‰āšēāš™
EBT excluding unusual items
6,03 āšĨāŧ‰āšēāš™
6,03 āšĨāŧ‰āšēāš™
3,47 āšĨāŧ‰āšēāš™
3,47 āšĨāŧ‰āšēāš™
Income tax expense
663,00
663,00
23,39Â āšžāšąāš™
23,39Â āšžāšąāš™
Effective tax rate
0,01%
0,01%
0,55%
0,55%
Other operating expenses
-1,88 āšĨāŧ‰āšēāš™
-1,88 āšĨāŧ‰āšēāš™
-149,67Â āšžāšąāš™
-149,67Â āšžāšąāš™
Net income
4,56 āšĨāŧ‰āšēāš™
4,56 āšĨāŧ‰āšēāš™
4,21 āšĨāŧ‰āšēāš™
4,21 āšĨāŧ‰āšēāš™
Net profit margin
68,04%
68,04%
53,76%
53,76%
Earnings per share
-
-
-
-
Interest and investment income
214,06Â āšžāšąāš™
214,06Â āšžāšąāš™
478,00
478,00
Interest expense
-1,41 āšĨāŧ‰āšēāš™
-1,41 āšĨāŧ‰āšēāš™
-1,37 āšĨāŧ‰āšēāš™
-1,37 āšĨāŧ‰āšēāš™
Net interest expenses
-1,19 āšĨāŧ‰āšēāš™
-1,19 āšĨāŧ‰āšēāš™
-1,37 āšĨāŧ‰āšēāš™
-1,37 āšĨāŧ‰āšēāš™
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
2,03Â āšžāšąāš™
2,03Â āšžāšąāš™
-
-
AI content may include mistakes. Learn more
āŧāš­āšąāššāš‚āš­āš‡ Google